Health-related quality of life (HRQOL) outcomes of oral ixazomib maintenance therapy post autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM) from tourmaline-MM3 — Fredrik Schjesvold (2019) | RDL Network
Health-related quality of life (HRQOL) outcomes of oral ixazomib maintenance therapy post autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM) from tourmaline-MM3
Fredrik Schjesvold, Hartmut Goldschmidt, Vladimír Maisnar, Niels Abildgaard, Philip Rowlings, Dawn Odom, Ari Gnanasakthy, Kaveri Suryanarayan, Lorna Cain, Dorothy Romanus, S. Vincent Rajkumar, Meletios A Dimopoulos
Meletios A Dimopoulos, Hartmut Goldschmidt, Vladimír Maisnar, Ivan Špıčka, Niels Abildgaard, Philip Rowlings, S. Vincent Rajkumar, Lauren E. Cain, Dorothy Romanus, Kaveri Suryanarayan, Dawn Odom, Ari Gnanasakthy, Fredrik Schjesvold
Fredrik Schjesvold, Hartmut Goldschmidt, Vladimír Maisnar, Ivan Špıčka, Neils Abildgaard, Philip Rowlings, Lauren E. Cain, Dorothy Romanus, Kaveri Suryanarayan, S. Vincent Rajkumar, Dawn Odom, Ari Gnanasakthy, Meletios A Dimopoulos
Meletios A Dimopoulos, Ivan Špıčka, Hang Quach, Albert Oriol, Roman Hájek, Mamta Garg, Meral Beksaç, Sara Bringhen, Eirini Katodritou, Wee Joo Chng, Xavier Leleu, Shinsuke Iida, María‐Victoria Mateos, Gareth J. Morgan, Alexander Vorog, Richard Labotka, Bingxia Wang, Antonio Palumbo, Sagar Lonial
Martin Kaiser, Meral Beksaç, Nina Gulbrandsen, Fredrik Schjesvold, Roman Hájek, Philippe Moreau, Felipe de Arriba, María‐Victoria Mateos, Sharon West, Andrew Spencer, S. Vincent Rajkumar, Kaveri Suryanarayan, Michael Czorniak, Cong Li, Zhaoyang Teng, Richard Labotka, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.